Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 45Alexion Pharmaceuticals

02 2AstraZeneca

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

RAVULIZUMAB-CWVZ

Brand Name : ULTOMIRIS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 300MG/30ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761108

Regulatory Info :

Registration Country : USA

blank

02

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomir

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date : 20/01/2020

Application Number : 67278

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

06

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

07

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

ravulizumab

Brand Name : Ultomiris

Dosage Form : Solution For Injection

Dosage Strength : 245mg/3.5ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

09

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

10

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

11

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 300MG

Packaging :

Approval Date : 11-06-2021

Application Number : 1191371002

Regulatory Info : Authorized

Registration Country : Spain

blank

12

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 1100MG

Packaging :

Approval Date : 11-06-2021

Application Number : 1191371003

Regulatory Info : Authorized

Registration Country : Spain

blank

13

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/ml

Packaging :

Approval Date : 18-11-2020

Application Number : 28106375119

Regulatory Info : Prescription

Registration Country : Denmark

blank

14

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 02-07-2019

Application Number : 28106141418

Regulatory Info : Prescription

Registration Country : Denmark

blank

15

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 18-11-2020

Application Number : 28106547619

Regulatory Info : Prescription

Registration Country : Denmark

blank

16

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/30ml

Packaging :

Approval Date : 02-07-2019

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

17

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 300mg/3ml

Packaging :

Approval Date : 18-11-2020

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

18

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1100mg/11ml

Packaging :

Approval Date : 18-11-2020

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

19

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

Ravulizumab

Brand Name : Ultomiris

Dosage Form : Injectable Solution

Dosage Strength : 245mg

Packaging :

Approval Date : 31-05-2023

Application Number : 2.02E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank

20

Asia Pharma Expo
Not Confirmed
arrow
arrow
Asia Pharma Expo
Not Confirmed

RAVULIZUMAB

Brand Name : ULTOMIRIS

Dosage Form : SOLUTION

Dosage Strength : 300MG/3ML

Packaging :

Approval Date :

Application Number : 2533448

Regulatory Info : Schedule D

Registration Country : Canada

blank